Contigo Compounding Pharmacy

Contigo Compounding Pharmacy (now operating as Eden Pharmacy) is an Albuquerque, New Mexico-based compounding pharmacy specializing in personalized, sterile, and non-sterile medications. Acquired by Eden Health in August 2025, the pharmacy serves as an in-house captive 503A compounding facility, providing custom formulations across various therapeutic areas, including weight loss (such as compounded GLP-1 therapies), hormone replacement therapy, hair loss, ophthalmology, and veterinary medicine. The company operates a state-of-the-art facility that is USP 797 and USP 800 compliant, offering sterile hazardous and non-hazardous compounding services. Following its acquisition, the facility is undergoing a $2.7 million expansion to integrate advanced automation and scale its operations to meet growing patient demand nationwide.